Roger L. Milne
- Oncology top 1%
- Molecular Biology top 5%
- Genetics top 1%
- Cancer Research top 2%
- Public Health, Environmental and Occupational Health top 2%
- Co-authors
- Graham G. GilesJohn L. HopperDallas R. EnglishMelissa C. SoutheyKelly‐Anne PhillipsMichael FriedländerAllison HodgePierre‐Antoine Dugué
- Topics
- BRCA gene mutations in cancer (60 papers)Cancer Risks and Factors (38 papers)Epigenetics and DNA Methylation (38 papers)
- Cited by
- OncologyCancer ResearchGenetics
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaBioinformatics
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Roger L. Milne
241 papers receiving 5.8k citations
Peers
Comparison fields: 5 of 152
- Oncology 2.0k
- Molecular Biology 1.8k
- Genetics 1.6k
- Cancer Research 943
- Public Health, Environmental and Occupational Health 839
Countries citing papers authored by Roger L. Milne
This map shows the geographic impact of Roger L. Milne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger L. Milne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger L. Milne more than expected).
Fields of papers citing papers by Roger L. Milne
This network shows the impact of papers produced by Roger L. Milne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger L. Milne. The network helps show where Roger L. Milne may publish in the future.
Co-authorship network of co-authors of Roger L. Milne
This figure shows the co-authorship network connecting the top 25 collaborators of Roger L. Milne. A scholar is included among the top collaborators of Roger L. Milne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger L. Milne. Roger L. Milne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 7 | |
| 3 | 7 | |
| 4 | 7 | |
| 5 | 1 | |
| 6 | 43 | |
| 7 | 21 | |
| 8 | 10 | |
| 9 | 12 | |
| 10 | 9 | |
| 11 | 2 | |
| 12 | 47 | |
| 13 | 5 | |
| 14 | 3 | |
| 15 | 22 | |
| 16 | 11 | |
| 17 | 61 | |
| 18 | 61 | |
| 19 | 94 | |
| 20 | 16 |
About Roger L. Milne
Roger L. Milne is a scholar working on Oncology, Genetics and Cancer Research, having authored 246 papers that have together received 5.9k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (60 papers), Cancer Risks and Factors (38 papers) and Epigenetics and DNA Methylation (38 papers). The work is most often cited by research in Oncology (2.0k citations), Cancer Research (943 citations) and Genetics (1.6k citations). Roger L. Milne has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Graham G. Giles, John L. Hopper, Dallas R. English, Melissa C. Southey, Kelly‐Anne Phillips, Michael Friedländer, Allison Hodge, Pierre‐Antoine Dugué, Julie K. Bassett and Nina Afshar. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Bioinformatics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.